Growth Metrics

Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 30.58%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 30.58%
Dec 31, 2025 2,368.38%
Sep 30, 2025 -7.22%
Jun 30, 2025 -36.90%
Mar 31, 2025 5.61%
Dec 31, 2024 -102.79%
Sep 30, 2024 53.07%
Jun 30, 2024 15.82%
Mar 31, 2024 -25.74%
Mar 31, 2023 495.75%
Mar 31, 2022 -1,351.06%
Dec 31, 2021 -107.28%
Sep 30, 2021 -106.75%
Jun 30, 2021 98.90%
Mar 31, 2021 100.92%
Dec 31, 2020 -13.94%
Sep 30, 2020 -45.12%
Jun 30, 2020 -257.85%
Mar 31, 2020 -306.78%
Dec 31, 2019 152.45%
Sep 30, 2019 176.62%
Jun 30, 2019 -28.66%
Mar 31, 2019 39.73%
Dec 31, 2018 -63.20%
Sep 30, 2018 64.07%
Jun 30, 2018 0.43%
Mar 31, 2018 -41.13%
Dec 31, 2017 -881.64%
Sep 30, 2017 -37.43%
Jun 30, 2017 680.76%
Mar 31, 2017 175.34%
Dec 31, 2016 286.86%
Sep 30, 2016 611.26%
Jun 30, 2016 81.76%
Mar 31, 2016 -36.47%
Dec 31, 2015 -159.02%
Sep 30, 2015 -87.16%
Jun 30, 2015 -198.69%
Mar 31, 2015 -22.61%
Dec 31, 2014 -50.86%
Sep 30, 2014 12.20%
Jun 30, 2014 16.08%
Mar 31, 2014 1.42%
Dec 31, 2013 -15.56%
Sep 30, 2013 -13.28%
Jun 30, 2013 -27.00%
Mar 31, 2013 7.92%
Dec 31, 2012 142.67%
Sep 30, 2012 -2.90%
Jun 30, 2012 1.96%
Mar 31, 2012 -3.30%
Dec 31, 2011 -1,122.64%
Sep 30, 2011 -4.24%
Jun 30, 2011 23.14%
Mar 31, 2011 1.70%
Dec 31, 2010 -77.51%
Sep 30, 2010 27.48%
Jun 30, 2010 -21.23%
Mar 31, 2010 1.58%